BNP Paribas Financial Markets’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $725K | Buy |
|
|||||
|
2025
Q2 | $238K | Buy |
|
|||||
|
2025
Q1 | $149K | Sell |
|
|||||
|
2024
Q4 | $260K | Sell |
|
|||||
|
2024
Q3 | $416K | Sell |
|
|||||
|
2024
Q2 | $484K | Sell |
|
|||||
|
2024
Q1 | $680K | Sell |
|
|||||
|
2023
Q4 | $1.32M | Sell |
|
|||||
|
2023
Q3 | $1.25M | Buy |
|
|||||
|
2023
Q2 | $412K | Sell |
|
|||||
|
2023
Q1 | $797K | Buy |
|
|||||
|
2022
Q4 | $255K | Sell |
|
|||||
|
2022
Q3 | $1.45M | Buy |
|
|||||
|
2022
Q2 | $382K | Sell |
|
|||||
|
2022
Q1 | $567K | Sell |
|
|||||
|
2021
Q4 | $1.58M | Sell |
|
|||||
|
2021
Q3 | $2.42M | Buy |
|
|||||
|
2021
Q2 | $419K | Sell |
|
|||||
|
2021
Q1 | $570K | Buy |
|
|||||
|
2020
Q4 | $216K | Buy |
|
|||||
|
2020
Q3 | $206K | Sell |
|
|||||
|
2020
Q2 | $326K | Sell |
|
|||||
|
2020
Q1 | $1.08M | Buy |
|
|||||
|
2019
Q4 | $346K | Sell |
|
|||||
|
2019
Q3 | $353K | Buy |
|
|||||
|
2019
Q2 | $251K | Sell |
|
|||||
|
2019
Q1 | $553K | Buy |
|
|||||
|
2018
Q4 | $174K | Sell |
|
|||||
|
2018
Q3 | $1M | Buy |
|
|||||
|
2018
Q2 | $470K | Sell |
|
|||||
|
2018
Q1 | $1.11M | Sell |
|
|||||
|
2017
Q4 | $1.18M | Sell |
|
|||||
|
2017
Q3 | $1.48M | Buy |
|
|||||
|
2017
Q2 | $748K | Sell |
|
|||||
|
2017
Q1 | $707K | Buy |
|
|||||
|
2016
Q4 | $594K | Buy |
|
|||||
|
2016
Q3 | $308K | Sell |
|
|||||
|
2016
Q2 | $706K | Buy |
|
|||||
|
2016
Q1 | $270K | Sell |
|
|||||
|
2015
Q4 | $521K | Buy |
|
|||||
|
2015
Q3 | $304K | Buy |
|
|||||
|
2015
Q2 | $147K | Buy |
|
|||||
|
2015
Q1 | $35.9K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $260K | Buy |
|
|||||
|
2014
Q2 | $1.5K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $12.1K | Sell |
|
|||||
|
2013
Q3 | $207K | Sell |
|
|||||
|
2013
Q2 | $231K | Buy |
|